SCHEMBL26565113

SCHEMBL26565113

CN1CCN(C(=O)c2cccc(Cc3n[nH]c(=O)c4ccc(Oc5ccc(C(N)=O)cc5)cc34)c2)CC1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26121784 0.86 PARP1 (0.70) PARP1
SCHEMBL26123915 0.76 PARP1 (0.62) PARP1
SCHEMBL30546079 0.76 PARP1 (0.62) PARP1
SCHEMBL4440359 0.75 PARP1 (1.00) PARP1
SCHEMBL1824686 0.74 PARP1 (0.86) PARP1
SCHEMBL30546228 0.74 PARP1 (0.60) PARP1
SCHEMBL26124715 0.74 PARP1 (0.60) PARP1
SCHEMBL1689488 0.73 PARP1 (1.00) PARP1
SCHEMBL30415984 0.73 PARP1 (1.00) PARP1
SCHEMBL77530 0.73 PARP1 (0.75) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed